Cargando…
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
BACKGROUND: SARS-CoV-2 viral infection causes COVID-19 that can result in severe acute respiratory distress syndrome (ARDS), which can cause significant mortality, leading to concern that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks for both infectio...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214323/ https://www.ncbi.nlm.nih.gov/pubmed/32464584 http://dx.doi.org/10.1016/j.msard.2020.102174 |